Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC
- Auteur
- BAHRUDIN, U1 2 3 ; IKEDA, N1 ; RIFQI, S3 ; SHIRAYOSHI, Y1 ; YAMAMOTO, K5 ; NINOMIYA, H6 ; HISATOME, I1 ; UTAMI, S. B1 3 ; MAHARANI, N1 4 ; MORIKAWA, K1 ; LI, P1 ; SOBIRIN, M. A3 4 ; HASEGAWA, A1 ; SAKATA, S1 ; ENDO, R1
[1] Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
[2] Center of Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[3] Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[4] Department of Pharmacology and Therapy, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[5] Department of Multidisciplinary Internal Medicine, School of Medicine, Tottori University, Yonago, Japan
[6] Department of Biological Regulation, Faculty of Medicine, Tottori University Yonago, Japan - Source
Drug research (Stuttgart. 2013. Print). 2013, Vol 63, Num 10, pp 515-520, 6 p ; ref : 38 ref
- ISSN
- 2194-9379
- Domaine scientifique
- Pharmacology drugs
- Editeur
- Thieme, Stuttgart
- Pays de publication
- Germany
- Type de document
- Article
- Langue
- English
- Mot clé auteur
- angiotensin receptor blocker apoptosis calcium channel blocker hypertrophic cardiomyopathy mutant cardiac myosin binding protein C
- Mot clé (fr)
- Antagoniste angiotensine Antagoniste calcium Antihypertenseur Apoptose Azelnidipine Cardiomyocyte Cardiomyopathie hypertrophique Coeur Inhibiteur Mort cellulaire Mutation Myosine Olmésartan Protéine C Protéine contractile Protéine liaison Traitement Anticoagulant naturel Récepteur AT1 de l'angiotensine II Appareil circulatoire Cardiopathie Dérivé de l'imidazole Dérivé de la dihydropyridine Dérivé du biphényle Dérivé du tétrazole Pathologie de l'appareil circulatoire Pathologie du myocarde Sartan dérivé
- Mot clé (en)
- Angiotensin antagonist Calcium antagonist Antihypertensive agent Apoptosis Azelnidipine Cardiomyocyte Hypertrophic cardiomyopathy Heart Inhibitor Cell death Mutation Myosin Olmesartan Protein C Contractile protein Binding protein Treatment Natural anticoagulant Circulatory system Heart disease Imidazole derivatives Dihydropyridine derivatives Biphenyl derivatives Tetrazole derivatives Cardiovascular disease Myocardial disease Sartan derivatives
- Mot clé (es)
- Antagonista angiotensina Antagonista calcio Antihipertensivo Apoptosis Azelnidipino Miocito cardíaco Cardiomiopatía hipertrófica Corazón Inhibidor Muerte celular Mutación Miosina Olmesartán Proteína C Proteína contráctil Proteína enlace Tratamiento Anticoagulante natural Aparato circulatorio Cardiopatía Imidazol derivado Dihidropiridine derivado Bifenilo derivado Tetrazol derivado Aparato circulatorio patología Miocardio patología Sartan derivado
- Classification
- Pascal
- 002 Sciences biologiques et medicales / 002B Sciences medicales / 002B12 Cardiologie. Appareil circulatoire / 002B12A Coeur / 002B12A05 Myocardites. Cardiomyopathies
- Discipline
- Cardiology. Circulatory system
- Provenance
- Inist-CNRS
- Base de données
- PASCAL
- Identifiant INIST
- 27843657
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Accès au Document
Installer sur votre navigateur
DOI
10.1055/s-0033-1347188 
https://dx.doi.org/10.1055/s-0033-1347188
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Accès par Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Europe PubMed Central
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Base Search
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par arXiv
